Clinical Trial Update: Comparison of Corneal Aberrations and Visual Outcomes in AcrySof IQ Toric Patients Versus Limbal Relaxing Incision (LRI) Patients [Phase 4]

View source ↗

Summary

Phase 4 trial comparing corneal aberrations and visual outcomes in patients receiving AcrySof IQ Toric intraocular lenses versus Limbal Relaxing Incisions has b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataracts

Drugs mentioned

• AcrySof IQ Toric (intraocular lens)

Snippet

Sponsor: Alcon Research | Conditions: Cataracts | Phase 4 | Status: WITHDRAWN